PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
25719248-6	2015	Glioblastoma cells treated with the DNA demethylation agent 5-azacytidine over 28 days of astrocyte-induced differentiation demethylated exon 2 of POLGA leading to increased mtDNA copy number and expression of the astrocyte endpoint marker glial fibrillary acidic protein (GFAP).	Azacitidine	60-73	glial fibrillary acidic protein	Homo sapiens	240-271	
25719248-6	2015	Glioblastoma cells treated with the DNA demethylation agent 5-azacytidine over 28 days of astrocyte-induced differentiation demethylated exon 2 of POLGA leading to increased mtDNA copy number and expression of the astrocyte endpoint marker glial fibrillary acidic protein (GFAP).	Azacitidine	60-73	glial fibrillary acidic protein	Homo sapiens	273-277	
25509416-5	2014	As induction of neuronal differentiation in the studied MSCs using differentiation medium containing B27 and N2 supplements, 5-azacytidine, retinoic acid, IBMX and dbcAMF caused changes in the cells morphology, the increased expression of beta-III-tubulin, and the appearance of neuronal markers GFAP, NF-H, NeuN and MAP2.	Azacitidine	125-138	glial fibrillary acidic protein	Homo sapiens	296-300	
30184215-6	2019	RESULTS: 5-Aza treatment has been found to reduce cell growth and increase expression of glial fibrillary acid protein (GFAP).	Azacitidine	9-14	glial fibrillary acidic protein	Homo sapiens	89-118	
30184215-6	2019	RESULTS: 5-Aza treatment has been found to reduce cell growth and increase expression of glial fibrillary acid protein (GFAP).	Azacitidine	9-14	glial fibrillary acidic protein	Homo sapiens	120-124